• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

琥珀酸脱氢酶复合物功能障碍的 KIT/PDGF 受体-α 野生型胃肠道间质瘤中 IGF-1 受体的表达。

Expression of IGF-1 receptor in KIT/PDGF receptor-α wild-type gastrointestinal stromal tumors with succinate dehydrogenase complex dysfunction.

机构信息

Department of Hematology & Oncological Sciences L&A Seràgnoli, S. Orsola-Malpighi Hospital, University of Bologna, Via Massarenti 9, 40138, Bologna, Italy.

出版信息

Future Oncol. 2013 Jan;9(1):121-6. doi: 10.2217/fon.12.170.

DOI:10.2217/fon.12.170
PMID:23252569
Abstract

KIT/PDGF receptor-α (PDGFRA) wild-type (WT) gastrointestinal stromal tumors (GIST) are characterized by an overexpression of IGF-1 receptor (IGF1R) at the mRNA and protein level. More recently, germline and somatic mutations in succinate dehydrogenase (SDH) subunits A, B and C have been identified in KIT/PDGFRA WT sporadic GIST. Until now, the molecular basis of IGF1R overexpression in KIT/PDGFRA WT GIST has not been explained. In this brief report we investigate the status of the SDH complex at the genomic and protein level in relation to IGF1R expression at the mRNA and protein level in seven KIT/PDGFRA WT sporadic GIST patients. We found that IGF1R was upregulated in all patients harboring SDH mutations or displaying a SDH dysfunction, with respect to KIT/PDGFRA WT GIST without SDH mutations. Western blot analysis confirmed that all patients with an upregulation of IGF1R mRNA had detectable IGF1R protein expression. This report would suggest that IGF1R overexpression in KIT/PDGFRA WT GIST could be driven by the loss-of-function of the SDH mitochondrial complex.

摘要

KIT/PDGF 受体-α(PDGFRA)野生型(WT)胃肠道间质瘤(GIST)的特征是 IGF-1 受体(IGF1R)在 mRNA 和蛋白水平上的过度表达。最近,在 KIT/PDGFRA WT 散发性 GIST 中已经鉴定出琥珀酸脱氢酶(SDH)亚基 A、B 和 C 的种系和体细胞突变。到目前为止,KIT/PDGFRA WT GIST 中 IGF1R 过度表达的分子基础尚未得到解释。在本简要报告中,我们研究了 7 例 KIT/PDGFRA WT 散发性 GIST 患者中 IGF1R 表达的 mRNA 和蛋白水平与 SDH 复合物在基因组和蛋白水平上的状态。我们发现,在所有携带 SDH 突变或显示 SDH 功能障碍的患者中,IGF1R 均上调,而 KIT/PDGFRA WT GIST 中则没有 SDH 突变。Western blot 分析证实,所有 IGF1R mRNA 上调的患者均有可检测到的 IGF1R 蛋白表达。本报告提示,KIT/PDGFRA WT GIST 中 IGF1R 的过度表达可能是由 SDH 线粒体复合物的功能丧失驱动的。

相似文献

1
Expression of IGF-1 receptor in KIT/PDGF receptor-α wild-type gastrointestinal stromal tumors with succinate dehydrogenase complex dysfunction.琥珀酸脱氢酶复合物功能障碍的 KIT/PDGF 受体-α 野生型胃肠道间质瘤中 IGF-1 受体的表达。
Future Oncol. 2013 Jan;9(1):121-6. doi: 10.2217/fon.12.170.
2
Integrating miRNA and gene expression profiling analysis revealed regulatory networks in gastrointestinal stromal tumors.整合微小RNA(miRNA)和基因表达谱分析揭示了胃肠道间质瘤中的调控网络。
Epigenomics. 2016 Oct;8(10):1347-1366. doi: 10.2217/epi-2016-0030. Epub 2016 Sep 14.
3
Molecular Subtypes of KIT/PDGFRA Wild-Type Gastrointestinal Stromal Tumors: A Report From the National Institutes of Health Gastrointestinal Stromal Tumor Clinic.KIT/PDGFRA 野生型胃肠道间质瘤的分子亚型:来自美国国立卫生研究院胃肠道间质瘤临床中心的报告。
JAMA Oncol. 2016 Jul 1;2(7):922-8. doi: 10.1001/jamaoncol.2016.0256.
4
Gene expression of the IGF pathway family distinguishes subsets of gastrointestinal stromal tumors wild type for KIT and PDGFRA.胰岛素样生长因子(IGF)通路家族的基因表达可区分 KIT 和 PDGFRA 野生型胃肠道间质瘤的亚群。
Cancer Med. 2013 Feb;2(1):21-31. doi: 10.1002/cam4.57. Epub 2013 Feb 3.
5
An overview on molecular biology of KIT/PDGFRA wild type (WT) gastrointestinal stromal tumours (GIST).KIT/PDGFRA 野生型(WT)胃肠道间质瘤(GIST)的分子生物学概述。
J Med Genet. 2013 Oct;50(10):653-61. doi: 10.1136/jmedgenet-2013-101695. Epub 2013 Jul 5.
6
Defects in succinate dehydrogenase in gastrointestinal stromal tumors lacking KIT and PDGFRA mutations.琥珀酸脱氢酶缺陷在缺乏 KIT 和 PDGFRA 突变的胃肠间质瘤中。
Proc Natl Acad Sci U S A. 2011 Jan 4;108(1):314-8. doi: 10.1073/pnas.1009199108. Epub 2010 Dec 20.
7
Classification of KIT/PDGFRA wild-type gastrointestinal stromal tumors: implications for therapy.KIT/PDGFRA野生型胃肠道间质瘤的分类:对治疗的意义。
Expert Rev Anticancer Ther. 2015 Jun;15(6):623-8. doi: 10.1586/14737140.2015.1032941. Epub 2015 Apr 1.
8
Overexpression of insulin-like growth factor 1 receptor and frequent mutational inactivation of SDHA in wild-type SDHB-negative gastrointestinal stromal tumors.胰岛素样生长因子 1 受体过表达和野生型 SDHB 阴性胃肠道间质瘤中 SDHA 的频繁突变失活。
Genes Chromosomes Cancer. 2013 Feb;52(2):214-24. doi: 10.1002/gcc.22023. Epub 2012 Oct 29.
9
Gastrointestinal stromal tumors - Summary of mutational status of the primary/secondary KIT/PDGFRA mutations, BRAF mutations and SDH defects.胃肠道间质瘤——原发/继发 KIT/PDGFRA 突变、BRAF 突变和 SDH 缺陷的突变状态总结。
Pathol Res Pract. 2019 Dec;215(12):152708. doi: 10.1016/j.prp.2019.152708. Epub 2019 Oct 29.
10
Analysis of all subunits, SDHA, SDHB, SDHC, SDHD, of the succinate dehydrogenase complex in KIT/PDGFRA wild-type GIST.KIT/PDGFRA野生型胃肠道间质瘤中琥珀酸脱氢酶复合物所有亚基SDHA、SDHB、SDHC、SDHD的分析
Eur J Hum Genet. 2014 Jan;22(1):32-9. doi: 10.1038/ejhg.2013.80. Epub 2013 Apr 24.

引用本文的文献

1
Exploring Perforated Jejunal GIST: A Rare Case Report and Review of Molecular and Clinical Literature.探索空肠穿孔性胃肠道间质瘤:一例罕见病例报告及分子与临床文献综述
Curr Issues Mol Biol. 2024 Feb 1;46(2):1192-1207. doi: 10.3390/cimb46020076.
2
Microvessel density in patients with gastrointestinal stromal tumors: A systematic review and meta-analysis.胃肠道间质瘤患者的微血管密度:一项系统评价和荟萃分析。
World J Methodol. 2023 Jun 20;13(3):153-165. doi: 10.5662/wjm.v13.i3.153.
3
Molecular Mechanisms of Gastrointestinal Stromal Tumors and Their Impact on Systemic Therapy Decision.
胃肠道间质瘤的分子机制及其对全身治疗决策的影响
Cancers (Basel). 2023 Feb 27;15(5):1498. doi: 10.3390/cancers15051498.
4
Correlation of treatment outcome in sanger/RT‑qPCR wild‑type metastatic gastrointestinal stromal tumors with next‑generation sequencing results: A single‑center report.桑格/实时荧光定量聚合酶链反应野生型转移性胃肠间质瘤的治疗结果与下一代测序结果的相关性:一项单中心报告。
Oncol Rep. 2022 Sep;48(3). doi: 10.3892/or.2022.8382. Epub 2022 Jul 29.
5
Targeted therapy in deficient GIST.针对缺陷性胃肠道间质瘤的靶向治疗。
Ther Adv Med Oncol. 2021 Jun 28;13:17588359211023278. doi: 10.1177/17588359211023278. eCollection 2021.
6
Prognostic Indicators for Gastrointestinal Stromal Tumors: A Review.胃肠道间质瘤的预后指标:综述
Transl Oncol. 2020 Oct;13(10):100812. doi: 10.1016/j.tranon.2020.100812. Epub 2020 Jun 28.
7
Activated tyrosine kinases in gastrointestinal stromal tumor with loss of KIT oncoprotein expression.胃肠道间质瘤中失去 KIT 癌蛋白表达的激活酪氨酸激酶。
Cell Cycle. 2018;17(23):2577-2592. doi: 10.1080/15384101.2018.1553335. Epub 2018 Dec 4.
8
The progressive fragmentation of the KIT/PDGFRA wild-type (WT) gastrointestinal stromal tumors (GIST).KIT/血小板衍生生长因子受体A(PDGFRA)野生型(WT)胃肠道间质瘤(GIST)的渐进性碎片化
J Transl Med. 2017 May 23;15(1):113. doi: 10.1186/s12967-017-1212-x.
9
Gastrointestinal stromal tumors (GIST): Facing cell death between autophagy and apoptosis.胃肠道间质瘤(GIST):面对自噬与凋亡之间的细胞死亡
Autophagy. 2017 Mar 4;13(3):452-463. doi: 10.1080/15548627.2016.1256522. Epub 2017 Jan 5.
10
Intratumoral KIT mutational heterogeneity and recurrent KIT/ PDGFRA mutations in KIT/PDGFRA wild-type gastrointestinal stromal tumors.KIT/血小板衍生生长因子受体A(PDGFRA)野生型胃肠道间质瘤中的瘤内KIT突变异质性及复发性KIT/PDGFRA突变
Oncotarget. 2016 May 24;7(21):30241-9. doi: 10.18632/oncotarget.7148.